Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
$2.18
+0.6%
$2.02
$1.21
$3.08
$80.95M-0.1585,314 shs24,783 shs
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
$0.66
-8.5%
$0.57
$0.16
$2.31
$65.61M0.8121.06 million shs11.30 million shs
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
$1.39
-1.7%
$1.32
$0.91
$1.80
$82.34M3.18113,930 shs37,111 shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$3.15
+0.5%
$3.96
$1.98
$7.95
$23.60M6.9383,144 shs105,739 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-1.81%-6.87%-22.50%+42.30%-17.18%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-3.19%+5.88%+46.48%+100.89%-46.87%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
+2.17%-7.84%+10.16%+0.71%+25.89%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-2.19%-2.19%-19.12%-54.11%+36.68%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
$2.18
+0.6%
$2.02
$1.21
$3.08
$80.95M-0.1585,314 shs24,783 shs
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
$0.66
-8.5%
$0.57
$0.16
$2.31
$65.61M0.8121.06 million shs11.30 million shs
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
$1.39
-1.7%
$1.32
$0.91
$1.80
$82.34M3.18113,930 shs37,111 shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$3.15
+0.5%
$3.96
$1.98
$7.95
$23.60M6.9383,144 shs105,739 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-1.81%-6.87%-22.50%+42.30%-17.18%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-3.19%+5.88%+46.48%+100.89%-46.87%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
+2.17%-7.84%+10.16%+0.71%+25.89%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-2.19%-2.19%-19.12%-54.11%+36.68%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
2.00
Hold$8.50289.19% Upside
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
2.83
Moderate Buy$8.001,110.29% Upside
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
2.00
Hold$4.00188.60% Upside
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.00
Hold$4.9256.33% Upside

Current Analyst Ratings Breakdown

Latest VVOS, EDAP, PSTV, and VANI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/8/2025
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/8/2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/6/2025
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$20.50 ➝ $21.00
9/27/2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/25/2025
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$5.00
9/18/2025
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$5.00
9/9/2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$6.20 ➝ $6.50
(Data available from 10/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
$69.18M1.18N/AN/A$1.18 per share1.85
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
N/AN/AN/AN/A($1.52) per shareN/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/AN/AN/AN/A$0.30 per shareN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$14.39M1.64N/AN/A$1.35 per share2.33
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-$20.58M-$0.61N/AN/AN/A-33.49%-56.85%-26.83%11/6/2025 (Estimated)
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-$12.98M-$2.24N/AN/AN/A-357.85%N/A-117.72%11/13/2025 (Estimated)
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$23.49M-$0.45N/AN/AN/AN/A-194.66%-68.64%11/12/2025 (Estimated)
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$11.14M-$1.68N/AN/AN/A-99.49%-232.76%-84.30%11/13/2025 (Estimated)

Latest VVOS, EDAP, PSTV, and VANI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/6/2025Q3 2025
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-$0.25N/AN/AN/A$15.05 millionN/A
8/19/2025Q2 2025
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.39-$0.55-$0.16-$0.55$3.37 million$3.82 million
8/14/2025Q2 2025
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
-$0.09-$0.01+$0.08-$0.01$1.08 million$1.39 million
8/13/2025Q2 2025
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$0.10-$0.12-$0.02-$0.12N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
N/AN/AN/AN/AN/A
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
N/AN/AN/AN/AN/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/AN/AN/AN/AN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.04
1.51
1.05
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
N/A
1.26
1.26
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/A
1.30
1.30
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
1.69
1.05
1.05

Institutional Ownership

CompanyInstitutional Ownership
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
62.74%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
3.28%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
6.78%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
26.35%

Insider Ownership

CompanyInsider Ownership
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.23%
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
0.79%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
46.40%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
23037.39 million37.31 millionOptionable
Plus Therapeutics, Inc. stock logo
PSTV
Plus Therapeutics
2099.27 million98.48 millionNot Optionable
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
2059.24 million31.76 millionOptionable
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
1607.51 million7.35 millionOptionable

Recent News About These Companies

Vivos Reports 7% Sales Drop

New MarketBeat Followers Over Time

Media Sentiment Over Time

EDAP TMS stock logo

EDAP TMS NASDAQ:EDAP

$2.18 +0.01 (+0.65%)
As of 01:08 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

Plus Therapeutics stock logo

Plus Therapeutics NASDAQ:PSTV

$0.66 -0.06 (-8.52%)
As of 01:13 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

Vivani Medical stock logo

Vivani Medical NASDAQ:VANI

$1.39 -0.02 (-1.70%)
As of 01:13 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Vivos Therapeutics stock logo

Vivos Therapeutics NASDAQ:VVOS

$3.14 +0.02 (+0.48%)
As of 01:11 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.